1.The efficacy of Turem in the treatment of chronic shoulder pain syndrome
Wu Ji Ming Zhu ; Munkhchimeg O ; Lagshmaa B ; Alimaa T
Mongolian Journal of Health Sciences 2025;85(1):79-84
Background:
When the incidence of the chronic shoulder pain syndrome is increasing year by year, it is necessary to
determine the effects of pain relief, recovery of joint disability, and impact on quality of life through clinical trial research
when calculating the results of Turem treatment, which is one of the main methods of traditional medical treatment.
Aim:
To study the effects of traditional medicine chiropractic on pain relief, mobility improvement, joint function recovery, and quality of life in chronic shoulder pain syndrome.
Materials and Methods:
The study was conducted using a single-blind, randomized controlled clinical trial (RCT) design. In the study, 60 clients were randomly selected from people suffering from of the shoulder joint pain, and group 1
received Turem treatment together with physical therapy, and group 2 received physical therapy. The results of the study
were evaluated by shoulder pain (VAS score), muscle strength, range of motion of the shoulder joint with a goniometer,
and the Disability of Arms, Shoulders, and Paws Questionnaire (DASH). The research was conducted in accordance with
the appropriate ethical approvals (No. 2024/3-05), (No. 2024-18) and confirmed by an informed consent form. Clinical
trial research results were processed using T-test, Independent T-test, repeated ANOWA test.
Results:
The average age of the participants in the study was 56.13±7.13 years in the treatment group and 53.87±8.05
years in the control group, and 55% were male and 45% female. When shoulder joint pain was evaluated by VAS assessment, the values before and after treatment and after 1 month of treatment in the turem treatment group and the control
group decreased statistically significantly (p=0.000). There was a statistical difference between the results of the 2 study
groups. When assessing muscle strength, no statistically significant difference was observed between the results of the
turem treatment and control groups. When measuring the amplitude of the shoulder joint in the subjects, the amplitude of
shoulder extension, abduction, external rotation, and inward rotation increased after the treatment, and compared to the
two groups, the index of the turem treatment group increased with statistical significance (p=0.000). When assessed by
the Hand, Shoulder, and Hand Dysfunction Questionnaire (DASH), the score of the questionnaire decreased significantly
(p=0.000) before, after, and after 1 month of treatment in the turem treatment group and the control group. Turem treatment has been shown to reduce the rate of shoulder disability and improve function in chronic shoulder pain syndrome.
Conclusion: Turem treatment for chronic shoulder pain syndrome can reduce shoulder pain, increase joint range, and
improve muscle strength. Also, turem treatment reduced the rate of shoulder disability and improved function.
Conclusion
Turem treatment for chronic shoulder pain syndrome can reduce shoulder pain, increase joint range, and
improve muscle strength. Also, turem treatment reduced the rate of shoulder disability and improved function.
2.An optimal medicinal and edible Chinese herbal formula attenuates particulate matter-induced lung injury through its anti-oxidative, anti-inflammatory and anti-apoptosis activities.
Huan ZHANG ; Jun KANG ; Wuyan GUO ; Fujie WANG ; Mengjiao GUO ; Shanshan FENG ; Wuai ZHOU ; Jinnan LI ; Ayesha T TAHIR ; Shaoshan WANG ; Xinjun DU ; Hui ZHAO ; Weihua WANG ; Hong ZHU ; Bo ZHANG
Chinese Herbal Medicines 2023;15(3):407-420
OBJECTIVE:
Identifying novel strategies to prevent particulate matter (PM)-induced lung injury is crucial for the reduction of the morbidity of chronic respiratory diseases. The combined intervention represented by herbal formulae for simultaneously targeting multiple pathological processes can provide a more beneficial effect than the single intervention. The aim of this paper is therefore to design a safe and effective medicinal and edible Chinese herbs (MECHs) formula against PM-induced lung injury.
METHODS:
PM-induced oxidative stress, inflammatory response and apoptosis A549 cell model were used to screen anti-oxidant, anti-inflammatory and anti-apoptotic MECHs, respectively. A network pharmacology method was utilized to rationally design a novel herbal formula. Ultra performance liquid chromatography-mass spectrometer was utilized to assess the quality control of MECHs formula. The excretion of magnetic iron oxide nanospheres of the MECHs formula was estimated in zebrafish. The MECH formula against PM-induced lung injury was investigated with mice experiments.
RESULTS:
Five selected herbs were rationally designed to form a new MECH formula, including Citri Exocarpium Rubrum (Juhong), Lablab Semen Album (Baibiandou), Atractylodis Macrocephalae Rhizoma (Baizhu), Mori Folium (Sangye) and Polygonati Odorati Rhizoma (Yuzhu). The formula effectively promoted the magnetic iron oxide nanospheres excretion in zebrafish. The mid/high dose formula significantly prevented PM-induced lung damage in mice by enhancing the activity of SOD and GSH-Px, reducing the MDA and ROS level and attenuating the upregulation of pro-inflammatory cytokine (IL-6, IL-8, IL-1β and TNF-α), down regulating the protein expression of NF-κB, STAT3 and Caspase-3.
CONCLUSION
Our findings suggest that the effective MECHs formula will become a novel strategy for preventing PM-induced lung injury and provide a paradigm for the development of functional foods using MECHs.
3.Efficacy of neoadjuvant therapy on HER2-positive breast cancer: a clinicopathological analysis.
P ZHU ; H LYU ; Q M BAI ; R H SHUI ; X L XU ; W T YANG
Chinese Journal of Pathology 2023;52(9):907-911
Objective: To investigate the efficacy of neoadjuvant therapy (NAT) on HER2-positive breast cancer and to analyze their clinicopathological features. Methods: A total of 480 cases of HER2-positive breast cancer who received neoadjuvant therapy (NAT), diagnosed at the Department of Pathology of Fudan University Shanghai Cancer Center from 2015 to 2020, were retrospectively identified. Clinicopathological parameters such as age, tumor size, molecular subtype, type of targeted therapy, Ki-67 proliferation index, ER and HER2 immunohistochemical expression, and HER2 amplification status were analyzed to correlate with the efficacy of NAT. Results: Among 480 patients with HER2-positive breast cancer, 209 achieved pathology complete response (pCR) after NAT, with a pCR rate of 43.5%. Of all the cases,457 patients received chemotherapy plus trastuzumab and 23 patients received chemotherapy with trastuzumab and pertuzumab. A total of 198 cases (43.3%) achieved pCR in patients with chemotherapy plus trastuzumab, and 11 cases (47.8%) achieved pCR in patients with chemotherapy plus trastuzumab and pertuzumab. The pCR rate in the latter group was higher, but there was no statistical significance. The results showed that the pCR rate of IHC-HER2 3+patients (49%) was significantly higher than that of IHC-HER2 2+patients (26.1%, P<0.001). The higher the mean HER2 copy number in the FISH assay, the higher the pCR rate was achieved. The expression level of ER was inversely correlated with the efficacy of NAT, and the pCR rate in the ER-positive group (28.2%) was significantly lower than that in the ER-negative group (55.8%, P<0.001). The pCR rate (29.1%) of patients with luminal B type was lower than that of HER2 overexpression type (55.8%, P<0.001). In addition, higher Ki-67 proliferation index was associated with higher pCR rate (P<0.001). The pCR rate was the highest in the tumor ≤2 cm group (57.7%), while the pCR rate in the tumor >5 cm group was the lowest (31.1%). The difference between the groups was significant (P=0.005). Conclusions: HER2 copy numbers, HER2 immunohistochemical expression level, molecular subtype, ER expression level and Ki-67 proliferation index are significantly associated with pCR after NAT. In addition, fluorescence in situ hybridization results, HER2/CEP17 ratio and tumor size could also significantly affect the efficacy of NAT.
China
;
In Situ Hybridization, Fluorescence
;
Ki-67 Antigen
;
Neoadjuvant Therapy
;
Retrospective Studies
;
Trastuzumab
;
Humans
;
Female
;
Breast Neoplasms/drug therapy*
4.The application of the non-woven fabric and filter paper "sandwich" fixation method in preventing the separation of the mucosal layer and muscular layer in mouse colon histopathological sections.
L SHEN ; Y T LI ; M Y XU ; G Y LIU ; X W ZHANG ; Y CHENG ; G Q ZHU ; M ZHANG ; L WANG ; X F ZHANG ; L G ZUO ; Z J GENG ; J LI ; Y Y WANG ; X SONG
Chinese Journal of Pathology 2023;52(10):1040-1043
5.Efficacy of polyetheretherketone rod hybrid surgery in preventing proximal junctional failure after adult spinal deformity surgery.
Y ZHAO ; B Y XU ; L T QI ; L YUE ; R L ZHU ; Z R YU ; X D YI ; C D LI
Chinese Journal of Surgery 2023;61(8):656-665
Objective: To investigate the clinical outcome and preventive effect of polyetheretherketone(PEEK) rod hybrid surgery on proximal junction failure(PJF) after long-segment fusion of adult spinal deformity. Methods: A retrospective study was conducted to analyze patients with degenerative scoliosis/kyphosis who underwent long-segment decompression and fusion surgery at Department of Orthopedics, Peking University First Hospital from January 2017 to December 2021. A total of 75 patients were included in the study, including 14 males and 61 females, aged (67.2±6.8)years (range:55 to 84 years). According to the operation method chosen by the patients, the patients were divided into PEEK rod hybrid group (20 cases) and traditional titanium rod group (55 cases). The general information of the patients was collected, and the coronal and sagittal parameters of the spine were measured before operation, at 1 month after operation, and at the last follow-up. The clinical effect of surgery was judged by the visual analogue scale (VAS) and Oswestry disability index (ODI). Whether proximal junctional kyphosis (PJK) and PJF occurred during the follow-up and the time of occurrence were recorded. Comparisons between groups were performed using independent sample t test, Mann-Whitney U test, χ2 test and Fisher's exact probability method. The data before and after surgery in the same group were compared using the paired sample t test and the Wilcoxon test. Results: There were no significant differences in age, gender, body mass index, bone mineral density, distal instrumented vertebrae, surgical segments, osteotomy method, operation time, and intraoperative bleeding between the two groups (all P>0.05). The follow-up time of the PEEK rod group was shorter(M(IQR)16.5(4.8) vs. 25.0(12.0),Z=-4.230,P<0.01). There were no significant differences in coronal, sagittal parameters, VAS and ODI between the two groups before operation (all P>0.05). Postoperative coronal Cobb angle, pelvic incidence, pelvic tilt, sacral slope, lumbar lordosis, thoracic kyphosis, sagittal vertical axis (SVA), VAS and ODI were significantly improved in both groups(all P<0.05). At the last follow-up, the SVA of the PEEK rod hybrid group was(3.74±2.40)cm, which was significantly lower than that of the titanium rod group (6.28±4.06)cm (t'=-3.318, P=0.002). At the last follow-up, the ODI of the PEEK rod hybrid group was 30.7±6.1, significantly better than the titanium rod group 39.3±17.2(t=-3.203, P=0.046). PJK occurred in 2 patients (10.0%) in the PEEK rod hybrid group, and no PJF phenomenon was observed. In the titanium rod group, 18 patients (32.7%) developed PJK, and 11 patients (20.0%) developed PJF. There was a statistically significant difference in the incidence of PJF between the PEEK rod hybrid group and the titanium rod group (P=0.031). Conclusions: PEEK rod hybrid surgery can achieve good clinical results in the treatment of adult spinal deformities. Compared with traditional titanium rod surgery, it can significantly reduce the incidence of postoperative PJF and improve the clinical function of patients.
Male
;
Female
;
Animals
;
Humans
;
Adult
;
Retrospective Studies
;
Titanium
;
Kyphosis/etiology*
;
Sacrum
;
Osteotomy/adverse effects*
;
Spinal Fusion/methods*
;
Lumbar Vertebrae
;
Treatment Outcome
;
Postoperative Complications/epidemiology*
6.Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report
Altaf MOHAMMED ; Roderick H. DASHWOOD ; Sally DICKINSON ; Mary L. DISIS ; Elizabeth M. JAFFEE ; Bryon D. JOHNSON 6 ; Samir N. KHLEIF ; Michael N. POLLAK ; Jeffrey SCHLOM ; Robert H. SHOEMAKER ; Sasha E. STANTON ; Georg T. WONDRAK ; Ming YOU ; Hao ZHU ; Mark Steven MILLER
Journal of Cancer Prevention 2021;26(4):309-317
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) convened the “Translational Advances in Cancer Prevention Agent Development (TACPAD) Workshop on Immunomodulatory Agents” as a virtual 2-day workshop on September 13 to 14, 2021. The main goals of this workshop were to foster the exchange of ideas and potentially new collaborative interactions among leading cancer immunoprevention researchers from basic and clinical research and highlight new and emerging trends in immunoprevention. The workshop included an overview of the mechanistic classes of immunomodulatory agents and three sessions covering the gamut from preclinical to clinical studies. The workshop convened individuals working in immunology and cancer prevention to discuss trends in discovery and development of immunomodulatory agents individually and in combination with other chemopreventive agents or vaccines.
7.Progress in next-generation sequencing research of non-syndromic oral clefts.
M Y WANG ; D J LIU ; H HUANG ; W Y LI ; R ZHOU ; H P ZHU ; Z B ZHOU ; T WU
Chinese Journal of Epidemiology 2018;39(3):387-390
Non-syndromic oral clefts (NSOC) are among the most common birth defects. The prevalence of NSOC is 1.13-1.30 per 1 000 live births in China, which is higher than those in other major ethnic groups. The etiology of NSOC is complex and heterogeneous, which involves both genetic and environmental risk factors. Although genome-wide association studies have identified a number of risk loci, these loci can only account for a small proportion of the heritability of NSOC. The next-generation sequencing research provides new ideas for further exploring the genetic risk factors of NSOC. This paper summaries the progress in the next-generation sequencing research of NSOC.
Asian People/genetics*
;
China
;
Cleft Lip/genetics*
;
Cleft Palate/genetics*
;
Ethnicity/genetics*
;
Genetic Predisposition to Disease
;
Genome-Wide Association Study
;
High-Throughput Nucleotide Sequencing
;
Humans
;
Polymorphism, Single Nucleotide
8.Dynamic variations of BMI and influencing factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Liuzhou, Guangxi Zhuang Autonomous Region, 2013-2014.
H H CHEN ; B T FU ; Q Y ZHU ; H X LU ; L H LUO ; L CHEN ; X H LIU ; X J ZHOU ; J H HUANG ; X X FENG ; G S SHAN ; Z Y SHEN
Chinese Journal of Epidemiology 2018;39(4):487-490
Objective: To understand the dynamic variation of BMI and influencing factors among HIV/AIDS patients receiving highly active anti-retroviral therapy (HAART) in Liuzhou, Guangxi Zhuang Autonomous Region (Guangxi). Methods: HIV/AIDS patients receiving HAART for the first time since 1 January 2013 were selected. Data on BMI was analyzed among patients receiving HAART at baseline,6 months and 12 months after treatment. By using the general linear model repeated measures of analysis of variance, BMI dynamic variations and influencing factors were described and analyzed. Results: The average BMI of 2 871 patients at baseline, 6th months and 12th months appeared as (20.65±3.32), (20.87±3.22) and (21.18±3.20), respectively, with differences all statistically significant (F=18.86, P<0.001). BMI were increasing over time with treatments (F=37.25, P<0.001). Main influencing factors were noticed as: age, sex, marital status, baseline data of CD(4)(+)T cells and the WHO classification on clinical stages. Conclusions: Higher proportion of BMI malnutrition counts was seen among patients before receiving HAART in Liuzhou. BMI of the patients that were on HAART seemed being influenced by many factors. It is necessary to select appropriate treatment protocols on different patients so as to improve the nutritional status of the patients.
Acquired Immunodeficiency Syndrome
;
Antiretroviral Therapy, Highly Active
;
Body Mass Index
;
CD4 Lymphocyte Count
;
China/epidemiology*
;
HIV Infections/drug therapy*
;
Humans
;
Linear Models
;
Marital Status
;
Nutritional Status
;
T-Lymphocytes
9.Transmitted drug resistance among HIV infected men who have sex with men in Tianjin, 2014-2017.
M N ZHENG ; T L NING ; N ZHOU ; X ZHAO ; L LI ; J J ZHU ; S H CHENG
Chinese Journal of Epidemiology 2018;39(5):619-624
Objective: To understand prevalence and transmission of transmitted drug resistance (TDR) among HIV infected men who have sex with men (MSM) in Tianjin from 2014 to 2017. Methods: A total of 225 blood samples were collected from HIV infected MSM in Tianjin from 2014 to 2017. Pol gene fragments were obtained by viral RNA extraction and nested PCR amplification. Phylogenetic and drug resistance analyses were conducted. Results: A total of 205 samples were successfully sequenced and analyzed. Based on pol sequences, 53.2% (109/205), 28.8% (59/205), 10.2% (21/205), 4.9% (10/205) and 2.9% (6/205) of the samples were positive for HIV subtypes CRF01_AE, CRF07_BC, B, CRF55_01B and unique recombinant forms (URFs). Twenty transmission clusters, including 75 sequences, were identified and 62.5% (10/16) of sequences with TDR were in 5 clusters. The prevalence of TDR was 7.8% between 2014 and 2017. The annual prevalence rate increased from 3.9% (2/51) in 2014, 5.7% (3/53) in 2015, 9.6% (5/52) in 2016 to 12.2%(6/49) in 2017, the difference was not significant (χ(2)=2.504, P=0.127). CRF01_AE and B strains had high TDR prevalence (3.4%, 7/205) and (2.9%, 6/205), respectively. The TDR mutation was mainly NNRTIs, the TDR prevalence was 6.3% (13/205). In contract, the TDR prevalence of NRTIs and PIs were 1.5% (3/205) and 1.0% (2/205) respectively. Conclusion: Results from this study suggested that the prevalence of HIV-1 TDR strains in MSM was serious in Tianjin. It is necessary to take effective prevention and control measures.
China
;
Drug Resistance, Viral/genetics*
;
Genes, pol
;
Genotype
;
HIV Infections/transmission*
;
HIV Reverse Transcriptase/genetics*
;
HIV Seropositivity/genetics*
;
HIV-1/isolation & purification*
;
Homosexuality, Male/statistics & numerical data*
;
Humans
;
Male
;
Mutation
;
Phylogeny
;
Polymerase Chain Reaction
;
Prevalence
;
RNA, Viral/genetics*
;
pol Gene Products, Human Immunodeficiency Virus/genetics*
10.General plan of Shanghai Diet and Health Survey.
Z N ZHU ; Y LU ; C F WU ; S R ZOU ; H LIU ; C F WANG ; B Z LUO ; H T YU ; M MI ; G Q WANG ; L B XIONG ; W J WANG ; C Y LUO ; J J ZANG ; Z Y WANG ; X D JIA ; X G FENG ; C Y GUO ; F WU
Chinese Journal of Epidemiology 2018;39(7):876-879
Shanghai Diet and Health Survey (SDHS) was designed to prospectively access local residents' food consumption, energy and nutrient intake, related chemical contaminant exposure, and the seasonal change trend to explore the relationship of diet with health. Data from SDHS can be used as fundamental information and scientific evidences for the development of local nutrition and food safety policies.
China
;
Diet
;
Energy Intake
;
Health Surveys
;
Nutrition Policy
;
Nutrition Surveys

Result Analysis
Print
Save
E-mail